BeyondSpring (BYSI)
BeyondSpring on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
2.4M
Short interest
settlement 2026-10-15
35.8
Days to cover
+33.3 days vs prior
36.8%
Short share of volume
2026-11-02
25
Fails to deliver
settlement 2026-10-09
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in BYSI is 2,353,319 shares, up 69,223 shares over the last month. Over the last 48 readings it ranged from 1,833,756 shares (31 March 2025) to 2,729,984 shares (14 August 2026). At the reported average volume of 66K shares a day that is 35.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/bysi" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,353,319 | -3.7% | 65,798 | 35.77 |
| 2026-09-30 | 2,444,531 | +7.0% | 996,338 | 2.45 |
| 2026-09-15 | 2,284,096 | -0.9% | 121,875 | 18.74 |
| 2026-08-31 | 2,305,776 | -15.5% | 114,458 | 20.15 |
| 2026-08-14 | 2,729,984 | +21.6% | 4,011,884 | 1.00 |
| 2026-07-31 | 2,244,595 | +0.8% | 20,602 | 108.95 |
| 2026-07-15 | 2,227,783 | +0.4% | 35,761 | 62.30 |
| 2026-06-30 | 2,219,018 | +0.6% | 23,618 | 93.95 |
| 2026-06-15 | 2,205,293 | -0.3% | 16,001 | 137.82 |
| 2026-05-29 | 2,213,130 | +1.3% | 36,796 | 60.15 |
| 2026-05-15 | 2,183,996 | -0.2% | 16,137 | 135.34 |
| 2026-04-30 | 2,188,849 | -0.2% | 7,772 | 281.63 |
| 2026-04-15 | 2,193,925 | -0.1% | 10,876 | 201.72 |
| 2026-03-31 | 2,196,528 | +0.4% | 23,931 | 91.79 |
| 2026-03-13 | 2,187,129 | -2.0% | 25,938 | 84.32 |
| 2026-02-27 | 2,231,450 | -0.2% | 15,930 | 140.08 |
| 2026-02-13 | 2,235,033 | -3.0% | 27,724 | 80.62 |
| 2026-01-30 | 2,302,940 | -3.9% | 26,462 | 87.03 |
| 2026-01-15 | 2,397,444 | -0.8% | 53,201 | 45.06 |
| 2025-12-31 | 2,417,807 | -7.1% | 173,250 | 13.96 |
| 2025-12-15 | 2,602,412 | +26.5% | 1,085,584 | 2.40 |
| 2025-11-28 | 2,057,163 | -0.5% | 25,979 | 79.19 |
| 2025-11-14 | 2,067,574 | -0.8% | 21,843 | 94.66 |
| 2025-10-31 | 2,084,315 | -1.0% | 61,002 | 34.17 |
| 2025-10-15 | 2,106,245 | -0.6% | 35,132 | 59.95 |
| 2025-09-30 | 2,119,867 | +0.8% | 46,859 | 45.24 |
| 2025-09-15 | 2,103,686 | -1.3% | 22,504 | 93.48 |
| 2025-08-29 | 2,130,655 | -0.5% | 30,609 | 69.61 |
| 2025-08-15 | 2,141,512 | -0.9% | 23,140 | 92.55 |
| 2025-07-31 | 2,161,757 | +1.2% | 30,647 | 70.54 |
| 2025-07-15 | 2,136,847 | +1.0% | 15,556 | 137.36 |
| 2025-06-30 | 2,115,804 | +11.7% | 207,346 | 10.20 |
| 2025-06-13 | 1,894,329 | +2.8% | 91,914 | 20.61 |
| 2025-05-30 | 1,842,748 | +0.0% | 5,817 | 316.79 |
| 2025-05-15 | 1,842,128 | +0.2% | 33,232 | 55.43 |
| 2025-04-30 | 1,838,012 | -0.3% | 18,612 | 98.75 |
| 2025-04-15 | 1,843,677 | +0.5% | 30,865 | 59.73 |
| 2025-03-31 | 1,833,756 | -1.7% | 17,623 | 104.05 |
| 2025-03-14 | 1,866,216 | -2.4% | 11,753 | 158.79 |
| 2025-02-28 | 1,911,479 | -1.0% | 8,245 | 231.83 |
| 2025-02-14 | 1,930,131 | -1.4% | 11,029 | 175.01 |
| 2025-01-31 | 1,957,452 | -0.3% | 15,037 | 130.18 |
| 2025-01-15 | 1,963,249 | -2.3% | 13,159 | 149.19 |
| 2024-12-31 | 2,009,856 | -4.1% | 29,362 | 68.45 |
| 2024-12-13 | 2,095,872 | -0.3% | 37,437 | 55.98 |
| 2024-11-29 | 2,103,262 | +1.2% | 18,176 | 115.72 |
| 2024-11-15 | 2,077,671 | -0.4% | 33,032 | 62.90 |
| 2024-10-31 | 2,086,178 | -1.1% | 14,614 | 142.75 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of BYSI volume is 36.8%, down 2.5 points over the last five sessions. Over the last 30 readings it ranged from 1.5% (23 September 2026) to 63.3% (28 September 2026). The latest reading is 2.5 points above the 30-session average of 34.4%, on 924K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 340K | 924K | 36.8% | 1,272 |
| 2026-10-30 | 66K | 149K | 44.0% | 0 |
| 2026-10-29 | 2K | 13K | 16.0% | 0 |
| 2026-10-28 | 3K | 19K | 14.8% | 0 |
| 2026-10-27 | 9K | 24K | 36.9% | 0 |
| 2026-10-26 | 10K | 26K | 39.3% | 0 |
| 2026-10-23 | 4K | 9K | 48.3% | 295 |
| 2026-10-22 | 15K | 40K | 36.9% | 0 |
| 2026-10-21 | 641 | 13K | 5.1% | 0 |
| 2026-10-20 | 3K | 30K | 9.5% | 0 |
| 2026-10-19 | 8K | 15K | 51.0% | 456 |
| 2026-10-16 | 2K | 6K | 33.4% | 0 |
| 2026-10-15 | 9K | 25K | 35.5% | 0 |
| 2026-10-14 | 10K | 16K | 59.2% | 0 |
| 2026-10-13 | 9K | 38K | 24.4% | 0 |
| 2026-10-12 | 6K | 14K | 45.5% | 462 |
| 2026-10-09 | 12K | 39K | 30.4% | 0 |
| 2026-10-08 | 19K | 37K | 50.8% | 0 |
| 2026-10-07 | 19K | 53K | 36.1% | 6,029 |
| 2026-10-06 | 19K | 69K | 27.0% | 0 |
| 2026-10-05 | 13K | 30K | 44.1% | 0 |
| 2026-10-02 | 8K | 26K | 30.8% | 0 |
| 2026-10-01 | 8K | 32K | 26.3% | 0 |
| 2026-09-30 | 76K | 124K | 60.8% | 17,790 |
| 2026-09-29 | 300K | 725K | 41.4% | 32,721 |
| 2026-09-28 | 1.4M | 2.2M | 63.3% | 11,953 |
| 2026-09-25 | 3K | 6K | 44.6% | 0 |
| 2026-09-24 | 1K | 8K | 14.3% | 0 |
| 2026-09-23 | 94 | 6K | 1.5% | 0 |
| 2026-09-22 | 2K | 9K | 23.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in BYSI is 25 shares, up 5 shares over the last settlement date. Over the last 30 readings it ranged from 20 shares (8 October 2026) to 138,717 shares (14 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 25 | $0.61 | $15 |
| 2026-10-08 | 20 | $0.64 | $13 |
| 2026-10-02 | 45,472 | $0.81 | $37K |
| 2026-10-01 | 73,796 | $0.77 | $57K |
| 2026-09-30 | 66,443 | $0.77 | $51K |
| 2026-09-29 | 79,766 | $1.12 | $89K |
| 2026-09-25 | 630 | $0.73 | $460 |
| 2026-09-24 | 1,773 | $0.71 | $1K |
| 2026-09-23 | 2,315 | $0.75 | $2K |
| 2026-09-22 | 2,818 | $0.74 | $2K |
| 2026-09-21 | 3,277 | $0.75 | $2K |
| 2026-09-18 | 1,109 | $0.71 | $787 |
| 2026-09-11 | 928 | $0.77 | $715 |
| 2026-09-03 | 4,299 | $0.61 | $3K |
| 2026-09-01 | 3,545 | $0.62 | $2K |
| 2026-08-28 | 4,177 | $0.64 | $3K |
| 2026-08-26 | 826 | $0.72 | $595 |
| 2026-08-18 | 86,787 | $0.71 | $62K |
| 2026-08-17 | 95,357 | $0.84 | $80K |
| 2026-08-14 | 138,717 | $1.00 | $139K |
| 2026-08-13 | 3,021 | $0.74 | $2K |
| 2026-08-12 | 2,350 | $0.79 | $2K |
| 2026-08-11 | 2,289 | $0.79 | $2K |
| 2026-08-07 | 1,607 | $0.87 | $1K |
| 2026-08-06 | 716 | $0.98 | $702 |
| 2026-08-05 | 14,181 | $0.99 | $14K |
| 2026-08-04 | 208 | $1.17 | $243 |
| 2026-07-30 | 265 | $1.15 | $305 |
| 2026-07-29 | 524 | $1.19 | $624 |
| 2026-07-24 | 74 | $1.08 | $80 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for BYSI in the last 90 days. The most recent filings are listed below. Latest filing: Huang Lan (Chief Executive Officer) on 2026-03-20.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | Huang Lan | Chief Executive Officer | Gift | 261K | $0.00 | $0 | 0 |
| 2025-10-17 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 46K | $1.76 | $80K | 1.5M |
| 2025-10-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 46K | $1.76 | $80K | 1.5M |
| 2025-10-16 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 86K | $1.72 | $148K | 1.6M |
| 2025-10-16 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 86K | $1.72 | $148K | 1.6M |
| 2025-10-15 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 18K | $1.65 | $30K | 1.7M |
| 2025-10-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 18K | $1.65 | $30K | 1.7M |
| 2025-10-14 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 28K | $1.65 | $47K | 1.7M |
| 2025-10-14 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 28K | $1.65 | $47K | 1.7M |
| 2025-10-13 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 107K | $1.70 | $183K | 1.7M |
| 2025-10-13 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 107K | $1.70 | $183K | 1.7M |
| 2025-10-10 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 2K | $1.77 | $4K | 1.8M |
| 2025-10-10 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $1.77 | $4K | 1.8M |
| 2025-10-09 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 4K | $1.81 | $7K | 1.8M |
| 2025-10-09 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 4K | $1.81 | $7K | 1.8M |
| 2025-10-08 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 8K | $1.77 | $13K | 1.8M |
| 2025-10-08 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 8K | $1.77 | $13K | 1.8M |
| 2025-10-07 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 2K | $1.79 | $4K | 1.8M |
| 2025-10-07 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $1.79 | $4K | 1.8M |
| 2025-10-06 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 18K | $1.78 | $31K | 1.8M |
| 2025-10-06 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 18K | $1.78 | $31K | 1.8M |
| 2025-10-03 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 600 | $1.76 | $1K | 1.8M |
| 2025-10-03 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 600 | $1.76 | $1K | 1.8M |
| 2025-10-02 | Cui Xiangmin | TenPercentOwner | Sell | 600 | $1.73 | $1K | 1.8M |
| 2025-10-02 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 600 | $1.73 | $1K | 1.8M |
| 2025-10-01 | Cui Xiangmin | TenPercentOwner | Sell | 3K | $1.80 | $5K | 1.8M |
| 2025-10-01 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 3K | $1.80 | $5K | 1.8M |
| 2025-09-30 | Cui Xiangmin | TenPercentOwner | Sell | 4K | $1.81 | $8K | 1.8M |
| 2025-09-30 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 4K | $1.81 | $8K | 1.8M |
| 2025-09-29 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 500 | $1.75 | $875 | 1.8M |
| 2025-09-29 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 500 | $1.75 | $875 | 1.8M |
| 2025-09-26 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 600 | $1.68 | $1K | 1.8M |
| 2025-09-26 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 600 | $1.68 | $1K | 1.8M |
| 2025-09-25 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 700 | $1.66 | $1K | 1.8M |
| 2025-09-25 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 700 | $1.66 | $1K | 1.8M |
| 2025-09-24 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 2K | $1.68 | $4K | 1.8M |
| 2025-09-24 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $1.68 | $4K | 1.8M |
| 2025-09-23 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 4K | $1.72 | $7K | 1.8M |
| 2025-09-23 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 4K | $1.72 | $7K | 1.8M |
| 2025-09-22 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 5K | $1.83 | $10K | 1.9M |
| 2025-09-22 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 5K | $1.83 | $10K | 1.9M |
| 2025-09-19 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 4K | $1.79 | $7K | 1.9M |
| 2025-09-19 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 4K | $1.79 | $7K | 1.9M |
| 2025-09-18 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 5K | $1.74 | $9K | 1.9M |
| 2025-09-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 5K | $1.74 | $9K | 1.9M |
| 2025-09-17 | Decheng Capital Global Healthcare GP, LLC | TenPercentOwner | Sell | 2K | $1.83 | $4K | 1.9M |
| 2025-09-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $1.83 | $4K | 1.9M |
| 2025-09-16 | Decheng Capital Global Healthcare Fund (Master), LP | TenPercentOwner | Sell | 840 | $1.88 | $2K | 1.9M |
| 2025-09-16 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 840 | $1.88 | $2K | 1.9M |
| 2025-09-15 | Decheng Capital Global Healthcare Fund (Master), LP | TenPercentOwner | Sell | 3K | $1.84 | $5K | 1.9M |
| 2025-09-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 3K | $1.84 | $5K | 1.9M |
| 2025-09-12 | Decheng Capital Global Healthcare Fund (Master), LP | TenPercentOwner | Sell | 700 | $1.85 | $1K | 1.9M |
| 2025-09-12 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 700 | $1.85 | $1K | 1.9M |
| 2025-09-11 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 4K | $1.90 | $7K | 1.9M |
| 2025-09-11 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 4K | $1.90 | $7K | 1.9M |
| 2025-09-10 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 8K | $1.93 | $16K | 1.9M |
| 2025-09-10 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 8K | $1.93 | $16K | 1.9M |
| 2025-09-09 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 9K | $1.97 | $18K | 1.9M |
| 2025-09-09 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 9K | $1.97 | $18K | 1.9M |
| 2025-09-08 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 7K | $1.93 | $14K | 1.9M |
| 2025-09-08 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 7K | $1.93 | $14K | 1.9M |
| 2025-09-05 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 1K | $1.86 | $2K | 1.9M |
| 2025-09-05 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 1K | $1.86 | $2K | 1.9M |
| 2025-09-04 | Decheng Capital Management III (Cayman), LLC | TenPercentOwner | Sell | 803 | $1.82 | $1K | 1.9M |
| 2025-09-04 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 803 | $1.82 | $1K | 1.9M |
| 2025-09-03 | Cui Xiangmin | TenPercentOwner | Sell | 1K | $1.81 | $2K | 1.9M |
| 2025-09-03 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 1K | $1.81 | $2K | 1.9M |
| 2025-09-02 | Cui Xiangmin | TenPercentOwner | Sell | 3K | $1.78 | $5K | 1.9M |
| 2025-09-02 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 3K | $1.78 | $5K | 1.9M |
| 2025-08-29 | Cui Xiangmin | TenPercentOwner | Sell | 800 | $1.74 | $1K | 1.9M |
| 2025-08-29 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 800 | $1.74 | $1K | 1.9M |
| 2025-08-28 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 809 | $1.81 | $1K | 1.9M |
| 2025-08-28 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 809 | $1.81 | $1K | 1.9M |
| 2025-08-27 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 1K | $1.78 | $2K | 1.9M |
| 2025-08-27 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 1K | $1.78 | $2K | 1.9M |
| 2025-08-26 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 2K | $1.79 | $4K | 1.9M |
| 2025-08-26 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $1.79 | $4K | 1.9M |
| 2025-08-25 | Decheng Capital Global Healthcare Fund (Master), LP | TenPercentOwner | Sell | 300 | $1.77 | $531 | 1.9M |
| 2025-08-25 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 300 | $1.77 | $531 | 1.9M |
| 2025-08-22 | Decheng Capital Global Healthcare Fund (Master), LP | TenPercentOwner | Sell | 2K | $1.75 | $4K | 1.9M |
| 2025-08-22 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $1.75 | $4K | 1.9M |
| 2025-08-21 | Decheng Capital Global Healthcare Fund (Master), LP | TenPercentOwner | Sell | 3K | $1.79 | $5K | 1.9M |
| 2025-08-21 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 3K | $1.79 | $5K | 1.9M |
| 2025-08-20 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 3K | $1.74 | $6K | 1.9M |
| 2025-08-20 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 3K | $1.74 | $6K | 1.9M |
| 2025-08-19 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 4K | $1.77 | $6K | 1.9M |
| 2025-08-19 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 4K | $1.77 | $6K | 1.9M |
| 2025-08-18 | Decheng Capital China Life Sciences USD Fund II, L.P. | TenPercentOwner | Sell | 48K | $2.03 | $97K | 1.9M |
| 2025-08-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 48K | $2.03 | $97K | 1.9M |
| 2025-08-15 | Cui Xiangmin | TenPercentOwner | Sell | 3K | $2.00 | $6K | 2.0M |
| 2025-08-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 3K | $2.00 | $6K | 2.0M |
| 2025-08-14 | Cui Xiangmin | TenPercentOwner | Sell | 2K | $2.00 | $4K | 2.0M |
| 2025-08-14 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $2.00 | $4K | 2.0M |
| 2025-08-04 | Cui Xiangmin | TenPercentOwner | Sell | 2K | $2.18 | $5K | 892K |
| 2025-08-04 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 2K | $2.18 | $5K | 892K |
| 2025-07-18 | Cui Xiangmin | TenPercentOwner | Sell | 900 | $2.20 | $2K | 894K |
| 2025-07-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 900 | $2.20 | $2K | 894K |
| 2025-07-17 | Cui Xiangmin | TenPercentOwner | Sell | 21K | $2.19 | $45K | 895K |
| 2025-07-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | Sell | 21K | $2.19 | $45K | 895K |
| 2025-07-16 | Cui Xiangmin | TenPercentOwner | Sell | 5K | $2.24 | $12K | 915K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of BYSI in their latest filing, all on Schedule 13G (passive). The largest reported stake is Lan Huang at 12.9% of the class (5,293,444 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-29 | 13G/Ano. 4 | Xiangmin Cuiindividual | 3.1M | 7.5% | 2026-09-30 |
| 2026-10-29 | 13G/Ano. 4 | Decheng Capital Management II (Cayman), LLCother entity | 1.6M | 3.9% | 2026-09-30 |
| 2026-10-29 | 13G/Ano. 4 | Decheng Capital China Life Sciences USD Fund II, L.P.partnership | 1.6M | 3.9% | 2026-09-30 |
| 2026-10-29 | 13G/Ano. 4 | Decheng Capital China Life Sciences USD Fund III, L.P.partnership | 1.4M | 3.5% | 2026-09-30 |
| 2026-10-29 | 13G/Ano. 4 | Decheng Capital Management III (Cayman), LLCother entity | 1.4M | 3.5% | 2026-09-30 |
| 2026-10-29 | 13G/Ano. 4 | Decheng Capital Global Healthcare Fund (Master), LPpartnership | 0 | 0.0% | 2026-09-30 |
| 2026-10-29 | 13G/Ano. 4 | Decheng Capital Global Healthcare GP, LLCother entity | n/a | 0.0% | 2026-09-30 |
| 2026-08-14 | 13G/Ano. 10 | Lan Huangindividual | 5.3M | 12.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Linqing Jiaindividual | 5.3M | 12.9% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Rosy Time Holdings Limitedother entity | 1 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Ever Regal Group Ltdother entity | 2 | 0.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 10 | Fairy Eagle Investments Limitedother entity | 1 | 0.0% | 2026-06-30 |
13F holders
Tracked managers holding BYSI at their latest 13F. JSON1 of the 30 tracked managers held BYSI at their latest 13F, $19K in total at quarter-end prices. Renaissance Technologies is the largest at $19K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 11K | $19K | 0.00% | -200 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn FY 2025 it generated -$19.8M of operating cash flow.
- Cash
- $2.7M
- Equity
- -$35.6M
- Total assets
- $14.6M
- Shares outstanding
- 41,119,820
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | n/a | -$849K | n/a | -0.02 |
| Q1 FY 2026 | 2026-03-31 | n/a | -$2.2M | n/a | -0.05 |
| Q4 FY 2025derived | 2025-12-31 | n/a | -$2.1M | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | n/a | -$1.5M | n/a | -0.04 |
| Q2 FY 2025 | 2025-06-30 | n/a | -$1.8M | n/a | -0.10 |
| Q1 FY 2025 | 2025-03-31 | n/a | $4.5M | n/a | 0.11 |
| Q4 FY 2024derived | 2024-12-31 | n/a | -$1.7M | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | n/a | -$2.1M | n/a | -0.05 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | n/a | -$1.0M | -$19.8M | $50K | n/a | n/a |
| FY 2024 | 2024-12-31 | n/a | -$11.1M | -$16.4M | $224K | n/a | n/a |
| FY 2023 | 2023-12-31 | n/a | -$21.0M | -$16.5M | $100K | n/a | n/a |
| FY 2022 | 2022-12-31 | n/a | -$33.3M | -$27.5M | $34K | n/a | n/a |
| FY 2021 | 2021-12-31 | n/a | -$64.2M | -$47.2M | $2.8M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
BeyondSpring in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows BeyondSpring (BYSI), SEC CIK 1677940, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-03-20.JSON and CSV
- Company record
- EDGAR filing index for CIK 1677940Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of BYSI is sold short?
2,353,319 shares were held short at the 2026-10-15 settlement, 35.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BYSI's daily short volume?
On 2026-11-02, 340,479 of the 924,369 BYSI shares reported to FINRA were sold short, 36.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BYSI have fails to deliver?
The SEC's latest file shows 25 BYSI shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are BYSI insiders buying or selling?
No open-market insider trades were reported for BYSI in the last 90 days. The most recent filings are listed below. Latest filing: Huang Lan (Chief Executive Officer) on 2026-03-20.
Who owns 5% or more of BYSI?
3 holders report 5% or more of BYSI in their latest filing, all on Schedule 13G (passive). The largest reported stake is Lan Huang at 12.9% of the class (5,293,444 shares), filed 2026-08-14 for an event on 2026-06-30.
What did BYSI report last quarter?
In FY 2025 it generated -$19.8M of operating cash flow.
Which tracked 13F managers own BYSI?
1 of the 30 tracked 13F managers held BYSI shares at their latest filing, $19K in all. The largest: Renaissance Technologies (11K shares, $19K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.